by John Gardella | Dec 11, 2018 | Community Involvement
This holiday season, the Clarendon Group, which manages the building in which CMBG3’s Boston office is located, spearheaded a holiday gift drive for children in need in Massachusetts. The drive asked tenants to pledge to support children served by the...
by John Gardella | Nov 6, 2018 | Appellate Litigation
On October 26, 2018, CMBG3 won on its appeal from a $1.6M verdict in a living mesothelioma case venued in Alameda County, California. In a 16-page opinion, the California Appellate Court found that the only evidence presented at trial against CMBG3’s client was...
by John Gardella | Sep 27, 2018 | Toxic Tort
On Tuesday, an 11 judge en banc panel in the Ninth Circuit court in California heard argument as to whether a prior three-judge Ninth Circuit panel erred in blocking a San Francisco ordinance requiring health warnings on sugary drinks. Under the ordinance, the warning...
by John Gardella | Sep 20, 2018 | Toxic Tort
Since its inception, CMBG3 has been following the emergence what we predicted will be one of the next big waves of litigation in the toxic torts world – the chemical, glysophate. Now, on the heels of a California jury awarding a plaintiff $289 million in damages...
by John Gardella | Aug 14, 2018 | Toxic Tort
CMBG3 Law previously reported on the start of the first trial in the country in which allegations that glysophate in Monsanto’s Roundup and Ranger Pro weed killers cause cancer are being presented to the jury. CMBG3’s Matt Lite has brought you the latest...
Recent Comments